COMMUNIQUÉS West-GlobeNewswire

AM Rx Announces Expanded Online Access and Insurance Support for Zepbound
23/06/2026
Telehealth company introduces an insurance-first weight-management pathway designed to help eligible patients navigate Zepbound coverage, prior authorization and ongoing virtual care New York, NY, June 23, 2026 (GLOBE [...]
FitRx Expands Online Weight-Management Program With Needle-Free Oral Semaglutide Option
23/06/2026
Telehealth program gives eligible patients access to a provider-reviewed daily capsule pathway alongside injectable and insurance-supported treatment options New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- FitRx today [...]
DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
23/06/2026
Châtillon, France, June 23, 2026 DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical- [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
23/06/2026
PALO ALTO, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support
23/06/2026
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity treatment through integrated [...]
RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
23/06/2026
MIAMI, June 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, [...]
GENFIT : Données positives de Phase 1b obtenues avec GNS561 en combinaison, dans une population de patients atteints de cholangiocarcinome lourdement prétraités
23/06/2026
Le médicament expérimental GNS561 a démontré un profil de sécurité et de tolérabilité favorable dans une étude de Phase 1b évaluant son potentiel en combinaison avec un inhibiteur de MEK (MEKi) Étude menée dans une [...]
Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 ($55,000 CAD based on current exchange rate) research grant to advance microbiota research in human health & disease
23/06/2026
MONTREAL, June 23, 2026 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to supporting scientific projects that explore the microbiome, is inviting grant [...]
Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs
23/06/2026
Data presented at the American Transplant Congress 2026 reports transvenous phrenic nerve stimulation reduced lung collapse and significantly increased availability of lungs that meet transplant criteria versus [...]
RoenRx Releases 2026 Weight-Loss Program Pricing and Treatment Cost Overview
23/06/2026
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- RoenRx , a telehealth platform providing medically supervised weight-loss care, today released updated 2026 pricing information for its weight-loss program, detailing [...]
Clever Care Health Plan Adds Veteran Medical, Economics, and Population Health Experts to Leadership Team After Reaching 51,000 Members
23/06/2026
New Chief Medical and Innovation Officer, Senior Vice President of Health Care Economics, and Vice President of Population Health Management Bring Decades of Experience to Support Clever Care’s Rapid Growth HUNTINGTON [...]
SK pharmteco lance SKyvec™, une plateforme unifiée de vecteurs viraux à haut rendement destinée à accélérer le développement des thérapies géniques, de la fabrication au patient
23/06/2026
RANCHO CORDOVA, Californie, 23 juin 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour le lancement de SKyvec™, sa plateforme exclusive et multimodale de vecteurs viraux. Conçue pour soutenir les programmes de [...]
Clariane announces the success of its offering of €333 million of hybrid notes
23/06/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane [...]
Clariane annonce le succès de son offre de 333 millions d’euros d’obligations hybrides
23/06/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
TogetherTuesday: Arizona Nonprofit Surpasses $6 Million for Childhood Blindness Research
23/06/2026
A Race Against Blindness highlights the power of partnerships, community, and collaboration in the race to save children’s vision GILBERT, Ariz., June 23, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness , the Arizona- [...]
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
23/06/2026
Investigational drug GNS561 showed a favorable safety and tolerability profile in a Phase 1b study evaluating its potential in combination with a MEK inhibitor (MEKi) Study conducted in a heavily pretreated, high - [...]
Applied Biologics Announces Submission of Abstract of Single-Layer Amniotic Membrane Plus Standard of Care for Chronic Diabetic Foot Ulcers: An Updated Analysis of The Campx Trial to SAWC Fall 2026
23/06/2026
SCOTTSDALE, Ariz, June 23, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
Premier Health of America Obtains Creditor Protection Under The CCAA-Operations to Continue Without Interruption
23/06/2026
MONTREAL, June 23, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“ Premier Health” or the “Company” ) announces that, further to its news release issued this morning and the hearing of the motion [...]
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
23/06/2026
Dr. Victor Fontenelle Bastos de Lima, an investigator on Nexalin’s recently completed Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 – Congress on Brain, Behavior and Emotions, held in Porto [...]

Pages